150 related articles for article (PubMed ID: 32502019)
1. Treatment of limb synovial sarcoma with metastasis at presentation.
Guo P; Zhao R; Zhou Y; Shen Y
Medicine (Baltimore); 2020 Jun; 99(23):e20550. PubMed ID: 32502019
[TBL] [Abstract][Full Text] [Related]
2. Clinical and strategic outcomes of metastatic synovial sarcoma on limb.
Jami SA; Mobarak SA; Jiandang S; Xi Z; Tanvir MMS; Monilal SS
Int J Health Sci (Qassim); 2020; 14(6):38-43. PubMed ID: 33192230
[TBL] [Abstract][Full Text] [Related]
3. Perioperative radiotherapy is associated with improved survival among patients with synovial sarcoma: A SEER analysis.
Naing KW; Monjazeb AM; Li CS; Lee LY; Yang A; Borys D; Canter RJ
J Surg Oncol; 2015 Feb; 111(2):158-64. PubMed ID: 25176165
[TBL] [Abstract][Full Text] [Related]
4. Synovial Sarcoma Is Not Associated With a Higher Risk of Lymph Node Metastasis Compared With Other Soft Tissue Sarcomas.
Jacobs AJ; Morris CD; Levin AS
Clin Orthop Relat Res; 2018 Mar; 476(3):589-598. PubMed ID: 29529647
[TBL] [Abstract][Full Text] [Related]
5. Factors Associated With Survival in Patients With Synovial Cell Sarcoma of the Head and Neck: An Analysis of 167 Cases Using the SEER (Surveillance, Epidemiology, and End Results) Database.
Mallen-St Clair J; Arshi A; Abemayor E; St John M
JAMA Otolaryngol Head Neck Surg; 2016 Jun; 142(6):576-83. PubMed ID: 27100936
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological Profile and Survival Outcomes in Patients with Localised Extremity Synovial Sarcomas.
Sharma J; Deo SVS; Kumar S; Barwad AW; Rastogi S; Sharma DN; Singh G; Bhoriwal S; Mishra A; K R; Saikia J; Mandal A; Bansal B; Gaur M
Clin Oncol (R Coll Radiol); 2024 Apr; 36(4):e97-e104. PubMed ID: 38326122
[TBL] [Abstract][Full Text] [Related]
7. Synovial sarcoma: the importance of size and location for survival.
Deshmukh R; Mankin HJ; Singer S
Clin Orthop Relat Res; 2004 Feb; (419):155-61. PubMed ID: 15021147
[TBL] [Abstract][Full Text] [Related]
8. [Synovial sarcoma of the extremities. Results of surgical and multimodal therapy].
Ulmer C; Kettelhack C; Tunn PU; Reichardt P; Hohenberger P; Schlag PM
Chirurg; 2003 Apr; 74(4):370-4. PubMed ID: 12719879
[TBL] [Abstract][Full Text] [Related]
9. Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity.
Lewis JJ; Antonescu CR; Leung DH; Blumberg D; Healey JH; Woodruff JM; Brennan MF
J Clin Oncol; 2000 May; 18(10):2087-94. PubMed ID: 10811674
[TBL] [Abstract][Full Text] [Related]
10. Limb-sparing surgery plus radiotherapy results in superior survival: an analysis of patients with high-grade, extremity soft-tissue sarcoma from the NCDB and SEER.
Ramey SJ; Yechieli R; Zhao W; Kodiyan J; Asher D; Chinea FM; Patel V; Reis IM; Wang L; Wilky BA; Subhawong T; Trent JC
Cancer Med; 2018 Sep; 7(9):4228-4239. PubMed ID: 30030882
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant chemotherapy in resectable synovial sarcoma.
Vining CC; Sinnamon AJ; Ecker BL; Kelz RR; Fraker DL; Roses RE; Karakousis GC
J Surg Oncol; 2017 Sep; 116(4):550-558. PubMed ID: 28580620
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the 7th and 8th version of the AJCC classification system for soft tissue sarcomas of extremities and trunk in patients with localised, intermediate or high-grade disease treated at European tertiary sarcoma centres.
Smolle MA; van de Sande M; Hayes A; Bergovec M; Smith HG; Liegl-Atzwanger B; Tunn PU; Niethard M; Windhager R; Szkandera J; Leithner A
Eur J Surg Oncol; 2021 Aug; 47(8):2182-2188. PubMed ID: 33865657
[TBL] [Abstract][Full Text] [Related]
13. Tendosynovial sarcoma. Clinicopathologic features, treatment, and prognosis.
Brodsky JT; Burt ME; Hajdu SI; Casper ES; Brennan MF
Cancer; 1992 Jul; 70(2):484-9. PubMed ID: 1319818
[TBL] [Abstract][Full Text] [Related]
14. The classic prognostic factors tumor stage, tumor size, and tumor grade are the strongest predictors of outcome in synovial sarcoma: no role for SSX fusion type or ezrin expression.
ten Heuvel SE; Hoekstra HJ; Bastiaannet E; Suurmeijer AJ
Appl Immunohistochem Mol Morphol; 2009 May; 17(3):189-95. PubMed ID: 18997619
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of conditional treatment effects of adjuvant treatments on patients with synovial sarcoma using Bayesian subgroup analysis.
Seo SW; Kim J; Son J; Lim S
BMC Med Inform Decis Mak; 2020 Dec; 20(1):320. PubMed ID: 33272256
[TBL] [Abstract][Full Text] [Related]
16. Follow-up after primary treatment of soft tissue sarcoma of extremities: impact of frequency of follow-up imaging on disease-specific survival.
Chou YS; Liu CY; Chen WM; Chen TH; Chen PC; Wu HT; Chiou HJ; Shiau CY; Wu YC; Liu CL; Chao TC; Tzeng CH; Yen CC
J Surg Oncol; 2012 Aug; 106(2):155-61. PubMed ID: 22297812
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant radiotherapy for pediatric and young adult nonrhabdomyosarcoma soft-tissue sarcoma.
Smith KB; Indelicato DJ; Knapik JA; Lagmay JP; Morris C; Kirwan JM; Zlotecki RA; Scarborough MT; Gibbs CP; Marcus RB
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):150-7. PubMed ID: 21550181
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic factors and adjuvant treatment effects on survival in adult head and neck synovial cell sarcoma.
Crowson MG; Lalich I; Keeney MG; Garcia JJ; Price DL
Head Neck; 2015 Mar; 37(3):375-80. PubMed ID: 24430934
[TBL] [Abstract][Full Text] [Related]
19. Grossly-resected synovial sarcoma treated by the German and Italian Pediatric Soft Tissue Sarcoma Cooperative Groups: discussion on the role of adjuvant therapies.
Brecht IB; Ferrari A; Int-Veen C; Schuck A; Mattke AC; Casanova M; Bisogno G; Carli M; Koscielniak E; Treuner J
Pediatr Blood Cancer; 2006 Jan; 46(1):11-7. PubMed ID: 16292743
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors that govern localized synovial sarcoma: a single institution retrospective study on 51 patients.
Yaser S; Salah S; Al-Shatti M; Abu-Sheikha A; Shehadeh A; Sultan I; Salem A; Sughayer M; Al-Loh S; Al-Mousa A
Med Oncol; 2014 Jun; 31(6):958. PubMed ID: 24770952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
